- Active not recruitingPHASE3
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
This study is testing a new medicine, crinecerfont, for adults with a condition called Congenital Adrenal Hyperplasia (CAH). It will compare crinecerfont to a dummy medicine to see if it's safe and helps manage CAH over about 20 months.
For: Congenital Adrenal HyperplasiaUnited States · Austria · Belgium - Active not recruitingPHASE3
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
This study is testing a new medicine, crinecerfont, for children and teenagers aged 2 to 17 with a type of Congenital Adrenal Hyperplasia (CAH). It compares the new medicine to a dummy pill (placebo) to see how well it works and if it's safe.
For: Congenital Adrenal HyperplasiaUnited States · Belgium · Canada